[新抗菌物质用于打击日益增长的耐药性]
Jasmin Tischer1,2, Nadine Dietze3, Kathrin Marx4
1Bereich Infektiologie und Tropenmedizin, Medizinische Klinik I (Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie), Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Deutschland.
Innere Medizin (Heidelberg, Germany)
|January 7, 2026
概括
抗菌素耐药性 (AMR) 在全球造成数百万人的死亡. 新的抗生素和治疗策略正在出现,以对抗多药耐药格拉姆阴性细菌 (MDRGN) 和其他耐药病原体.
科学领域:
- 全球卫生健康 全球卫生健康
- 传染病 传染病 传染病
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗菌素耐药性 (AMR) 是一个重大的全球健康威胁,每年造成数百万人的死亡.
- 多药耐药生物 (MDROs),特别是格拉姆阴性细菌 (MDRGN) 是一个主要问题.
- 世卫组织确定了特定的有问题的病原体,如耐药的肠杆菌,Pseudomonas aeruginosa和Acinetobacter baumannii.
研究的目的:
- 审查最近在打击抗微生物药物耐药性的进展.
- 突出新批准的抗生素和治疗策略.
- 讨论抗生素开发和监管方法的不断变化的格局.
主要方法:
- 审查最近的药物批准和临床试验数据.
- 分析新的抗生素类别,组合和新的治疗方式.
- 审查影响抗生素分类和评估的监管变化.
主要成果:
- 几种新的抗生素和β-乳酸/β-乳酸酶抑制剂组合已被批准用于MDRGN感染.
- 新的药物如塞菲德罗科尔 (cefiderocol),埃拉瓦环素 (eravacycline) 和达尔巴万辛 (dalbavancin) 提供了更多的治疗选择.
- 抗生素开发管道显示了新型候选药物和多种治疗方法的更新活动.
结论:
- 最近的制药创新为治疗耐药感染提供了更多的选择.
- 监管框架正在适应,以促进对新抗生素的评估.
- 对单克隆抗体和细菌菌体等新型药物的持续研究有望为未来的向治疗提供希望.
相关概念视频
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Antimicrobial Effectiveness
897
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
897
Biological Methods for Microbial Control
776
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
776
Antimicrobial Proteins
12.9K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.9K
Antibiotic Selection
59.3K
Overview
59.3K
Chemical Agents for Microbial Control
746
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
746


